Prof. Jyh-Hong Chen

Academic Degree(s)



Current Position

  • Vice President, China Medical University
  • Dean and Professor, College of Medicine, China Medical University



  • 2007 National Quality Award (國家品質獎)
  • 2008 Taiwan Business Award (台灣企業獎,傑出管理人獎)
  • 2000 Research Awards A National Cheng-Kung University Medical College
  • 1999 National Science Council, Executive Yuan, Taipei, Taiwan


Selected Publication

  • Sruart J Connolly, Michael D. Ezekowitz, Salim Yusuf, D.Phil., john Eikelboom, Jonas Oldgren, Amit Parekh, Janice Pogue, Paul A. Reilly, Ellison Themeles, Jeanne Varrone, Susan Wang, Marco Alings, Denis Xavier, Jun Zhu, Rafael Diaz, Basil S. Lewis, Harald Darius, Hans-Christoph Diener, Campbell D. ( 2009 ) Joyner, Lars Wallentin, and the RE-LY Steering Committee and Investigators, (JH Chen is one of the members of steering committee). Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med.
  • LIU PY, LIU YW, LIN LJ, CHEN JH, LIAO JK (2008). Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on ROCK Activity, Endothelial Function, and Inflammation. Circulation.
  • LIU PY, CHEN JH, LIN LJ and James K. LIAO (2007). Incerased Rho kinase (ROCK) activity in a taiwanese population with metabolic syndrome. J Am Coll Cardiol.
  • LIU PY, LI LH, CHAO TH, WU HL, LIN LJ, TSAI LM and CHEN JH (2007). Synergistic effect of cytochrome P450 epoxygenase CYP2J2 7 polymorphism with smoking on the onset of premature myocardial infarction. Atherosclerosis.
  • TSAI WC, LI YH, HUANG YY, LIN CC, CHAO TH and CHEN JH (2006). Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension. Clinical Science.
  • LIU PY, LI YH, CHANG SH, LIN LJ, WU HL, SHI GY and CHEN JH (2006). Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. The American journal of cardiology.
  • LIU PY, LI YH, WU HL, CHAO TH, TSAI LM, LIN LJ, SHI GY and CHEN JH (2006). Platelet-activating factor-acetyl hydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction. Journal of thrombosis and haemostasis : JTH.